Altimmune (ALT) Current Leases (2020 - 2026)
Altimmune's (ALT) quarterly Current Leases came in at $265000.0 in Q1 2026, up 8.16% year-on-year from $245000.0 in Q1 2025, and up 3.52% on a QoQ basis from $256000.0 in Q4 2025.
Altimmune (ALT) Current Leases (2020 - 2026) Analysis & Trends
Altimmune (ALT) has 7 years of Current Leases data on file, last reported at $265000.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 8.16% year-over-year to $265000.0 in Q1 2026; TTM through Mar 2026 was $265000.0, a 8.16% increase from a year earlier, with the FY2025 full-year figure at $256000.0, down 8.24% from the prior year.
- Current Leases for Q1 2026 stood at $265000.0, up from $256000.0 in the prior quarter.
- Over the last five years, Current Leases for ALT reached as high as $508000.0 in Q1 2024 and fell as low as $239000.0 in Q2 2025.
- Historically, Current Leases has averaged $374176.5 across 5 years, with a median of $421000.0 in 2022.
- Across the five-year window, Current Leases gained 9.98% in 2023 and sank 51.77% in 2025, its largest moves.
- Year by year, Current Leases stood at $452000.0 in 2022, then increased by 9.73% to $496000.0 in 2023, then sank by 43.75% to $279000.0 in 2024, then slipped by 8.24% to $256000.0 in 2025, then increased by 3.52% to $265000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $265000.0 in Q1 2026, $256000.0 in Q4 2025, and $247000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | 265,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 265,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 247,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 245,000.00 |
| Dec 31, 2024 | 279,000.00 |
| Sep 30, 2024 | 313,000.00 |
| Jun 30, 2024 | 345,000.00 |
| Mar 31, 2024 | 508,000.00 |
| Dec 31, 2023 | 496,000.00 |
| Sep 30, 2023 | 485,000.00 |
| Jun 30, 2023 | 474,000.00 |
| Mar 31, 2023 | 463,000.00 |
| Dec 31, 2022 | 452,000.00 |
| Sep 30, 2022 | 442,000.00 |
| Jun 30, 2022 | 431,000.00 |
| Mar 31, 2022 | 421,000.00 |
| Dec 31, 2021 | 411,000.00 |
| Dec 31, 2020 | 356,716.00 |